Cargando…

Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus

BACKGROUND: Main portal vein tumor thrombus (MPVTT), which has a high incidence, is the major complication of terminal liver cancer. The occurrence of MPVTT is always a negative prognostic factor for patients with hepatocellular carcinoma (HCC). Therefore, attention should be paid to the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yue, Wu, Yi-Fan, Yue, Zhen-Dong, Zhao, Hong-Wei, Wang, Lei, Fan, Zhen-Hua, He, Fu-Liang, Wang, Tao, Liu, Fu-Quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Retrospective Cohort Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475673/ https://www.ncbi.nlm.nih.gov/pubmed/31040896 http://dx.doi.org/10.4251/wjgo.v11.i4.310

Ejemplares similares

Transjugular intrahepatic portosystemic shunt with radioactive seed strand for main portal vein tumor thrombosis with cirrhotic portal hypertension
por: Yan, Xuan-Hui, et al.
Publicado: (2022)

Stents combined with iodine-125 implantation to treat main portal vein tumor thrombus
por: Wu, Yi-Fan, et al.
Publicado: (2018)

Prognosis after splenectomy plus pericardial devascularization vs transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding
por: Qi, Wei-Li, et al.
Publicado: (2023)

Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy
por: Luo, Shi-Hua, et al.
Publicado: (2019)

Safety and efficacy of transfemoral intrahepatic portosystemic shunt for portal hypertension: A single-center retrospective study
por: Zhang, Yu, et al.
Publicado: (2019)

Stent fracture after transjugular intrahepatic portosystemic shunt placement using the bare metal stent/stent-graft combination technique
por: Liu, Qi-Jia, et al.
Publicado: (2023)

Incidence of portal vein thrombosis after splenectomy and its influence on transjugular intrahepatic portosystemic shunt stent patency
por: Dong, Fang, et al.
Publicado: (2019)

Transjugular Intrahepatic Portosystemic Shunt Versus Surgical Shunting in the Management of Portal Hypertension
por: Huang, Long, et al.
Publicado: (2015)

Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome
por: Zhou, Chun-Ze, et al.
Publicado: (2020)

Transjugular intrahepatic portosystemic shunt and splenectomy are more effective than endoscopic therapy for recurrent variceal bleeding in patients with idiopathic noncirrhotic portal hypertension
por: He, Fu-Liang, et al.
Publicado: (2020)

Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt
por: Luo, Shi-Hua, et al.
Publicado: (2017)

Segmental intrahepatic cholestasis as a technical complication of the transjugular intrahepatic porto-systemic shunt
por: Bucher, Julian Nikolaus, et al.
Publicado: (2019)

Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications
por: Luo, Shi-Hua, et al.
Publicado: (2023)

Use of doppler ultrasound to predict need for transjugular intrahepatic portosystemic shunt revision
por: Duong, Nikki, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension
por: Tripathi, Dhiraj, et al.
Publicado: (2020)

Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
por: Wang, Zhong, et al.
Publicado: (2021)

Transjugular intrahepatic portosystemic shunt via left hepatic – left portal veins
por: Maleux, Geert
Publicado: (2019)

Transsplenic portal vein reconstruction–transjugular intrahepatic portosystemic shunt in a patient with portal and splenic vein thrombosis
por: Salsamendi, Jason T., et al.
Publicado: (2016)

The Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Current Status
por: Pomier-Layrargues, Gilles, et al.
Publicado: (2012)

A novel nomogram predicting overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in portal hypertension patients
por: Liao, Yong, et al.
Publicado: (2023)

Techniques and long-term effects of transjugular intrahepatic portosystemic shunt on liver cirrhosis-related thrombotic total occlusion of main portal vein
por: Wang, Lei, et al.
Publicado: (2017)

Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma
por: Luo, Shi-Hua, et al.
Publicado: (2019)

Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes
por: Hsu, Michael C, et al.
Publicado: (2017)

Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma
por: Luo, Xuefeng, et al.
Publicado: (2014)

Transjugular Intrahepatic Portosystemic Shunt as the Treatment for Refractory Hepatic Hydrothorax with Portal Vein Thrombosis
por: Zhang, Lin-Hao, et al.
Publicado: (2017)

Clinical efficacy of transjugular intrahepatic portosystemic shunt in the treatment of hepatopulmonary syndrome
por: Zhao, Hongwei, et al.
Publicado: (2017)

The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips
por: Fanelli, Fabrizio
Publicado: (2014)

The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls
por: Lee, Hae Lim, et al.
Publicado: (2022)

Advanced portal venous access techniques for transjugular intrahepatic portosystemic shunt placement
por: Partovi, Sasan, et al.
Publicado: (2021)

Transjugular intrahepatic portosystemic shunt for pediatric portal hypertension: A meta-analysis
por: Raissi, Driss, et al.
Publicado: (2023)

Effects of transjugular intrahepatic portosystemic shunt using the Viatorr stent on hepatic reserve function in patients with cirrhosis
por: Yao, Xin, et al.
Publicado: (2021)

Parallel Shunt for the Treatment of Transjugular Intrahepatic Portosystemic Shunt Dysfunction
por: Luo, Xuefeng, et al.
Publicado: (2013)

Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature
por: Qi, Xingshun, et al.
Publicado: (2011)

Transjugular intrahepatic portosystemic shunt for Budd–Chiari syndrome with diffuse occlusion of hepatic veins
por: He, Fuliang, et al.
Publicado: (2016)

Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020
por: Horhat, Adelina, et al.
Publicado: (2021)

Clinical efficacy of antiviral therapy in patients with hepatitis B-related cirrhosis after transjugular intrahepatic portosystemic shunt
por: Yao, Xin, et al.
Publicado: (2021)

Transjugular intrahepatic portosystemic shunt vs conservative treatment for recurrent ascites: A propensity score matched comparison
por: Philipp, Martin, et al.
Publicado: (2022)

Portal vein thrombosis before and after transjugular intrahepatic portosystemic shunt placement: An observational study (STROBE compliant)
por: Wan, Yue-Meng, et al.
Publicado: (2017)

Transjugular intrahepatic portosystemic shunt for the prevention of rebleeding in patients with cirrhosis and portal vein thrombosis: Systematic review and meta-analysis
por: Guo, Ding-Fan, et al.
Publicado: (2022)

Transjugular Intrahepatic Portosystemic Shunt for Maintenance of Portal Venous Patency in Liver Transplant Candidates
por: Gaba, Ron Charles, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_os6ber5epnh91g1s749d4t65im